Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rich

Showing results (81-90 of 181) with videos related to

Pageof 19
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2015
Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasisR G Langley, P Rich, A Menter, et al.
Human Gene Therapy|February 1, 1994
Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epitheliumM J Welsh, A E Smith, J Zabner, et al.
Journal of Medicinal Chemistry|October 1, 1974
Structure-activity relationships in psychotomimetic phenylalkylaminesF A Aldous, B C Barrass, K Brewster, et al.
Molecular and Cellular Biology|August 1, 1991
Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2R J Gregory, D P Rich, S H Cheng, et al.
The British Journal of Dermatology|February 1, 2013
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding studyP Rich, B Sigurgeirsson, D Thaci, et al.
Nature|September 27, 1990
Expression and characterization of the cystic fibrosis transmembrane conductance regulatorR J Gregory, S H Cheng, D P Rich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2019
Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acneU Blume-Peytavi, J Fowler, L Kemény, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2020
A Preclinical Safety Study of Thyroid Hormone Instilled into the Lungs of Healthy Rats-an Investigational Therapy for ARDSCraig M Flory, Beverly J Norris, Nicole A Larson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 3, 2016
Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3P van de Kerkhof, L Guenther, A B Gottlieb, et al.
Human Gene Therapy|August 1, 1993
Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosisD P Rich, L A Couture, L M Cardoza, et al.
Pageof 19

Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2015
Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasisR G Langley, P Rich, A Menter, et al.
Human Gene Therapy|February 1, 1994
Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epitheliumM J Welsh, A E Smith, J Zabner, et al.
Journal of Medicinal Chemistry|October 1, 1974
Structure-activity relationships in psychotomimetic phenylalkylaminesF A Aldous, B C Barrass, K Brewster, et al.
Molecular and Cellular Biology|August 1, 1991
Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2R J Gregory, D P Rich, S H Cheng, et al.
The British Journal of Dermatology|February 1, 2013
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding studyP Rich, B Sigurgeirsson, D Thaci, et al.
Nature|September 27, 1990
Expression and characterization of the cystic fibrosis transmembrane conductance regulatorR J Gregory, S H Cheng, D P Rich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2019
Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acneU Blume-Peytavi, J Fowler, L Kemény, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 31, 2020
A Preclinical Safety Study of Thyroid Hormone Instilled into the Lungs of Healthy Rats-an Investigational Therapy for ARDSCraig M Flory, Beverly J Norris, Nicole A Larson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 3, 2016
Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3P van de Kerkhof, L Guenther, A B Gottlieb, et al.
Human Gene Therapy|August 1, 1993
Development and analysis of recombinant adenoviruses for gene therapy of cystic fibrosisD P Rich, L A Couture, L M Cardoza, et al.
Pageof 19